Just FYI

In the last earnings call Al said...

"In addition to those 2 key trials, a few other studies not yet reported will also be included in the resubmission."

It would appear that they are the following:

Healthy Normal Volunteers Looking at Exposure and Effects of Multiple Doses of Technosphere® Insulin (TI) Using the Gen2C Inhaler

Comparison of Technosphere Insulin Inhalation Powder & Subcutaneous Rapid-Acting Analog in Subjects With Type 1 Diabetes

Pharmacokinetic Study in Healthy Volunteers

Safety and Efficacy of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder)When an Optimal Dose is Taken With Varied Carbohydrate Intake

The above studies are completed since the last CRL or are scheduled to be completed by the time of resubmission.(#'s 13, 16,24 and 28)

#27 is still recruiting and isn't scheduled to be done until December 2013.It involves 510 patients:

Evaluate Safety of Technosphere® Insulin Inhalation Powder (TI Inhalation Powder) on Diabetic Subjects With Mild Obstructive Pulmonary Disease

You can find them all here...

http://www.clinicaltrials.gov/ct2/results?term=mannkind&pg=1&show_flds=Y